The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Internationalization of Chinese Pharmaceutical Firms-Strategies and Drivers
Abstract
Investigating how pharmaceutical firms from emerging economies internationalize themselves to meet the knowledge- and investment-intensive challenges of pharmaceutical industry has become an inviting topic for both academia and industry. This paper explores the internationalization strategies and driving factors of Chinese pharmaceutical firms. Through applying text analytics, four internationalization patterns of Chinese pharmaceutical firms are identified, namely, (1) market seeking by the state-owned; (2) opportunity exploring by the emerging-private; (3) culture penetration by TCM firms; and (4) global integration by CROs. It shows that the internationalization of Chinese pharmaceutical firms is driven by three key factors: firm ownership, business scope and value chain positioning. This study attempts not only to provide empirical evidence of internationalization of Chinese pharmaceutical firms, but also to contribute to the field of study on corporate internationalization in the complex-system sector.
Related Content
|
Monia Ben Ltaifa, Walid Chouari, Abdelkader Mohamed Sghaier Derbali.
© 2024.
30 pages.
|
|
Filiz Mızrak.
© 2024.
21 pages.
|
|
Aytaç Gökmen.
© 2024.
12 pages.
|
|
Maria Aweis Mayow, Aytaç Gökmen, Dilek Temiz.
© 2024.
27 pages.
|
|
Ahlem Baccouche, Houssem Bouzgarrou, Meriem Jouirou, Moufida Ben Saada.
© 2024.
21 pages.
|
|
Ashwani Panesar, Rohit Sood.
© 2024.
20 pages.
|
|
Boussairi Slimani, Moufida Ben Saada, Sameh Halaoua.
© 2024.
22 pages.
|
|
|